InvestorsHub Logo
Followers 5
Posts 554
Boards Moderated 0
Alias Born 04/17/2012

Re: None

Thursday, 12/19/2013 12:57:36 AM

Thursday, December 19, 2013 12:57:36 AM

Post# of 704365
Folks, below is a link to Nature's outlook on Cancer Immunotherapy. The video describes the story of a cancer survivor and though the methodology of the cancer vaccine is different from NWBO's (perhaps complementary) an important point the doctor conducting the trial makes is how, after almost 30 years of reserach and a lot of hard work, the time for cancer immunotherapy, and cancer vaccines, is finally here.

http://www.nature.com/nature/outlook/cancer-immunotherapy/index.html#editorial


Two other things that struck me were - 1) A reinforcment of the excellent toxicity/safety profile of immunotherapeutic cancer vaccines 2) The critical importance of manufacturing to scaling up vaccine production, if efficacy merits an FDA approval.

On the latter point, NWBO as done a lot of hard work that has gone unappreciated. So far.

The next couple of days should be interesting. I'm with ou in that I don't think Linda will let the Board Meeting pass off as a non-event. But regardless of that, the period from now until Feb-end should be very eventful for us.

Good luck to us all !
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News